BioSpace News Archive

CareDx, Inc.CareDx, Inc.CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, reported financial results for the third quarter ended September 30, 2021.

In addition to sales growth analysis versus 2020, we are including sales growth versus 2019 as 2019 provides a more normal baseline for comparison given the variability caused by the COVID-19 pandemic throughout 2020.

Today, overall survival (OS) data from Eli Lilly and Company’s (NYSE: LLY) Verzenio® (abemaciclib) Phase 3 monarchE study were published in a Letter to the Editor in the Annals of Oncology.

Amgen (NASDAQ: AMGN) today announced that it will report its third quarter financial results on Tuesday, November 2, 2021, after the close of the U.S. financial markets.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and financial results for the third quarter ending September 30, 2021.

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, reported financial results for the quarter ended September 30, 2021.

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced that it has ranked as the top company to work for in Science’s 2021 Top Employers Survey.

ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced the presentation of preclinical data characterizing the mechanism of action of EPI-7386, ESSA’s lead product candidate for the treatment of prostate cancer.

DexCom, Inc. reported its financial results as of and for the quarter ended September 30, 2021.

Seagen Inc. reported financial results for the third quarter and nine months ended September 30, 2021.